Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
RKDA logo RKDA
Upturn stock ratingUpturn stock rating
RKDA logo

Arcadia Biosciences Inc (RKDA)

Upturn stock ratingUpturn stock rating
$4.4
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $12

1 Year Target Price $12

Analysts Price Target For last 52 week
$12 Target price
52w Low $2.53
Current$4.4
52w High $6.44

Analysis of Past Performance

Type Stock
Historic Profit -54.53%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 6.02M USD
Price to earnings Ratio -
1Y Target Price 12
Price to earnings Ratio -
1Y Target Price 12
Volume (30-day avg) 1
Beta 0.51
52 Weeks Range 2.53 - 6.44
Updated Date 08/15/2025
52 Weeks Range 2.53 - 6.44
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.57

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -38.34%
Operating Margin (TTM) -101.67%

Management Effectiveness

Return on Assets (TTM) -30.68%
Return on Equity (TTM) -7.95%

Valuation

Trailing PE -
Forward PE 36.63
Enterprise Value 2883811
Price to Sales(TTM) 1.15
Enterprise Value 2883811
Price to Sales(TTM) 1.15
Enterprise Value to Revenue 0.55
Enterprise Value to EBITDA 0.62
Shares Outstanding 1367040
Shares Floating 1355830
Shares Outstanding 1367040
Shares Floating 1355830
Percent Insiders 0.82
Percent Institutions 5.59

ai summary icon Upturn AI SWOT

Arcadia Biosciences Inc

stock logo

Company Overview

overview logo History and Background

Arcadia Biosciences, Inc. was founded in 2004. It focuses on developing and commercializing agricultural products to enhance the environment and human health. They have evolved from a research and development company to commercializing their own products.

business area logo Core Business Areas

  • Arcadia Wellnessu2122: Focuses on developing and marketing innovative food and beverage products under brands like GoodWheatu2122 and Zolau00ae.
  • Arcadia GoodWheatu2122: Specialty wheat ingredients with enhanced fiber and protein content.

leadership logo Leadership and Structure

The leadership team includes Stan Jacot as CEO. The company has a standard corporate structure with a board of directors and various executive positions.

Top Products and Market Share

overview logo Key Offerings

  • GoodWheatu2122 Pasta: Pasta made from high fiber GoodWheat. Market share data is not readily available. Competitors include conventional pasta brands and other high-fiber pasta alternatives. Revenue is small but growing rapidly.
  • GoodWheatu2122 Flour: High-fiber, gluten-reduced flour for baking. Market share data is not readily available. Competitors include traditional wheat flour brands and alternative flours. Revenue is small but growing rapidly.
  • Zolau00ae Coconut Water: A refreshing beverage product. Market share data is not readily available. Competitors include Vita Coco and other coconut water brands. Revenue is small but growing rapidly.

Market Dynamics

industry overview logo Industry Overview

The agricultural technology industry is growing, driven by increasing demand for sustainable and healthy food options.

Positioning

Arcadia Biosciences is positioned as an innovator in crop improvement and food technology, with a focus on creating healthier food products. The Total Addressable Market (TAM) is in the billions as people seek to eat healthier.

Total Addressable Market (TAM)

Upturn SWOT Analysis

Strengths

  • Innovative technology platform
  • Focus on healthy and sustainable food
  • Proprietary wheat varieties
  • Strong IP portfolio

Weaknesses

  • Limited commercial scale
  • Dependence on key products
  • Ongoing losses
  • Need for additional capital

Opportunities

  • Growing demand for healthy food options
  • Partnerships with food companies
  • Expansion into new markets
  • Increased adoption of GoodWheatu2122 products

Threats

  • Competition from established agricultural companies
  • Regulatory hurdles
  • Consumer acceptance of new technologies
  • Fluctuations in commodity prices

Competitors and Market Share

competitor logo Key Competitors

  • KRFT
  • GIS
  • ADM

Competitive Landscape

Arcadia Biosciences faces competition from larger, more established companies in the food and agriculture industries. Arcadia's advantage lies in its innovative technology and focus on healthy food options.

Growth Trajectory and Initiatives

Historical Growth: Arcadia Biosciences has shown significant growth in revenue in recent years, but the overall market is small.

Future Projections: Analysts project continued revenue growth, but profitability is not expected in the near term.

Recent Initiatives: Arcadia has focused on scaling up GoodWheatu2122 production and expanding its distribution channels.

Summary

Arcadia Biosciences is an innovative company with compelling technology and a strong focus on healthy food options. The company faces challenges related to commercial scale and financial stability, indicating that they need to improve on scaling out and reaching a bigger audience. Despite recent revenue growth, profitability remains a concern. Successfully scaling their production and distribution channels will be critical for future success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings, analyst reports, industry publications, and online sources.

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market data is subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Arcadia Biosciences Inc

Exchange NASDAQ
Headquaters Dallas, TX, United States
IPO Launch date 2015-05-15
CEO, President & Director Mr. Thomas J. Schaefer C.F.A.
Sector Consumer Defensive
Industry Packaged Foods
Full time employees 9
Full time employees 9

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.